IMMUNE GLOBULIN SUBCUTANEOUS (HUMAN)

IMMUNE GLOBULIN SUBCUTANEOUS (HUMAN) was reported 4615 times

IMMUNE GLOBULIN SUBCUTANEOUS (HUMAN) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OSMOPHOBIA 3 0.1875
1 MICROCOCCAL SEPSIS 3 0.1500
2 LACK OF INFUSION SITE ROTATION 5 0.1042
3 ALLERGY TO IMMUNOGLOBULIN THERAPY 6 0.0550
4 INFUSION SITE MASS 47 0.0432
5 ANTIACETYLCHOLINE RECEPTOR ANTIBODY POSITIVE 3 0.0400
6 INFUSION SITE PRURITUS 101 0.0320
7 INFUSION SITE SCAR 14 0.0316
8 BLOOD IMMUNOGLOBULIN G ABNORMAL 5 0.0299
9 INFUSION SITE DISCOMFORT 31 0.0299
10 INFUSION SITE SWELLING 172 0.0273
11 INFUSION SITE BRUISING 57 0.0264
12 INFUSION SITE HAEMORRHAGE 84 0.0255
13 MENINGOENCEPHALITIS VIRAL 4 0.0226
14 DILATED PORES 2 0.0220
15 INFUSION SITE URTICARIA 14 0.0209
16 SELECTIVE IGA IMMUNODEFICIENCY 3 0.0204
17 INFUSION SITE RASH 28 0.0204
18 INFUSION SITE DISCHARGE 35 0.0199
19 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 11 0.0196
20 INFUSION SITE NODULE 18 0.0187
21 INFUSION SITE PAIN 237 0.0184
22 INFUSION SITE ERYTHEMA 152 0.0180
23 ANTI-GAD ANTIBODY POSITIVE 2 0.0179
24 OMPHALITIS 5 0.0177
25 MALABSORPTION FROM ADMINISTRATION SITE 4 0.0172
26 BLOOD IMMUNOGLOBULIN A DECREASED 11 0.0169
27 IMMUNOGLOBULINS DECREASED 23 0.0167
28 INFUSION SITE HYPERSENSITIVITY 2 0.0167
29 CEREBELLAR ISCHAEMIA 3 0.0161
30 INADVERTENT INJECTION AIR BUBBLE 2 0.0159
31 INFUSION SITE WARMTH 19 0.0155
32 IMMUNOGLOBULINS ABNORMAL 4 0.0153
33 INFUSION SITE VESICLES 8 0.0152
34 IMMUNOGLOBULINS INCREASED 7 0.0150
35 INFUSION SITE IRRITATION 19 0.0148
36 INCORRECT DRUG ADMINISTRATION RATE 60 0.0141
37 INFUSION SITE REACTION 42 0.0140
38 DEVICE INFUSION ISSUE 34 0.0137
39 BACTERIAL ABDOMINAL INFECTION 2 0.0136
40 BASOSQUAMOUS CARCINOMA 2 0.0134
41 INFUSION SITE EXTRAVASATION 80 0.0128
42 IMMUNODEFICIENCY COMMON VARIABLE 6 0.0123
43 INFUSION SITE DISCOLOURATION 10 0.0114
44 INFUSION SITE INFLAMMATION 8 0.0113
45 BLOOD IMMUNOGLOBULIN G DECREASED 26 0.0105
46 HERPES SIMPLEX TEST POSITIVE 2 0.0101
47 ALLERGY TO VACCINE 3 0.0097
48 COVID-19 IMMUNISATION 8 0.0096
49 INFUSION SITE OEDEMA 8 0.0096
50 BOREDOM 3 0.0088
51 INFUSION SITE INDURATION 13 0.0088
52 OESOPHAGEAL MOTILITY DISORDER 3 0.0083
53 MENINGITIS ASEPTIC 37 0.0082
54 BLOOD IMMUNOGLOBULIN G INCREASED 10 0.0082
55 SINUSITIS BACTERIAL 8 0.0076
56 DEATH OF RELATIVE 3 0.0074
57 CATHETER SITE THROMBOSIS 2 0.0073
58 DERMAL ABSORPTION IMPAIRED 2 0.0071
59 EXCESSIVE SKIN 2 0.0071
60 ALLERGIC SINUSITIS 6 0.0070
61 IMMUNISATION REACTION 5 0.0069
62 LOCAL REACTION 5 0.0067
63 DEVICE RELATED BACTERAEMIA 2 0.0065
64 DEVICE PROGRAMMING ERROR 2 0.0063
65 CHRONIC SINUSITIS 23 0.0061
66 MULTIPLE ALLERGIES 48 0.0061
67 VOCAL CORD DYSFUNCTION 3 0.0061
68 ROOT CANAL INFECTION 3 0.0061
69 GASTROINTESTINAL MICROORGANISM OVERGROWTH 2 0.0057
70 RESPIRATORY TRACT INFECTION VIRAL 13 0.0056
71 OCCIPITAL NEURALGIA 3 0.0053
72 INSURANCE ISSUE 81 0.0053
73 URINARY TRACT INFECTION FUNGAL 3 0.0052
74 CROUP INFECTIOUS 4 0.0051
75 HYPERTENSIVE ENCEPHALOPATHY 3 0.0051
76 INFUSION RELATED HYPERSENSITIVITY REACTION 3 0.0050
77 VACCINATION COMPLICATION 4 0.0049
78 NOROVIRUS INFECTION 7 0.0048
79 SINUSITIS 495 0.0048
80 CORONA VIRUS INFECTION 2 0.0047
81 ENCEPHALITIS CYTOMEGALOVIRUS 2 0.0046
82 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 6 0.0044
83 FEEDING INTOLERANCE 2 0.0044
84 EAR INFECTION 114 0.0043
85 INFUSION SITE HAEMATOMA 2 0.0042
86 ANIMAL SCRATCH 4 0.0041
87 LIQUID PRODUCT PHYSICAL ISSUE 30 0.0041
88 HAEMOPHILUS INFECTION 4 0.0041
89 EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) 2 0.0040
90 BODY TEMPERATURE ABNORMAL 7 0.0038
91 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 3 0.0038
92 SINUSITIS FUNGAL 3 0.0037
93 POOR VENOUS ACCESS 38 0.0037
94 INFECTED BITE 3 0.0035
95 SEASONAL ALLERGY 50 0.0035
96 CELLULITIS ORBITAL 2 0.0034
97 MULTIMORBIDITY 4 0.0033
98 INFECTED CYST 4 0.0033
99 POST-ACUTE COVID-19 SYNDROME 4 0.0032
100 VENOUS INJURY 3 0.0032
101 VASCULAR PAIN 3 0.0031
102 INFECTIOUS MONONUCLEOSIS 7 0.0031
103 RHINOVIRUS INFECTION 12 0.0031
104 DUST ALLERGY 3 0.0031
105 PRODUCT DISTRIBUTION ISSUE 28 0.0030
106 BRONCHITIS VIRAL 2 0.0030
107 MENINGITIS VIRAL 4 0.0029
108 INJECTION SITE OEDEMA 5 0.0029
109 GASTROINTESTINAL VIRAL INFECTION 3 0.0029
110 EYE CONTUSION 6 0.0028
111 BLOOD SODIUM ABNORMAL 3 0.0028
112 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 4 0.0028
113 BITE 2 0.0028
114 STREPTOCOCCAL INFECTION 15 0.0027
115 RESPIRATORY TRACT INFECTION 70 0.0027
116 SINUS DISORDER 53 0.0027
117 SKIN INFECTION 30 0.0027
118 AUTOIMMUNE THYROIDITIS 10 0.0026
119 LIGAMENT INJURY 3 0.0026
120 CORTISOL DECREASED 3 0.0026
121 UPPER RESPIRATORY TRACT INFECTION 121 0.0026
122 ADMINISTRATION SITE PAIN 3 0.0026
123 ALLERGIC COUGH 2 0.0026
124 BACTERIAL VAGINOSIS 4 0.0026
125 DEVICE DISPENSING ERROR 3 0.0025
126 KIDNEY INFECTION 49 0.0025
127 DERMATITIS CONTACT 28 0.0025
128 STAPHYLOCOCCAL SKIN INFECTION 3 0.0024
129 INABILITY TO AFFORD MEDICATION 24 0.0024
130 ALLERGY TO CHEMICALS 3 0.0024
131 GASTROENTERITIS SALMONELLA 2 0.0024
132 MEDICAL PROCEDURE 4 0.0024
133 LYME DISEASE 8 0.0024
134 CEREBRAL VENOUS SINUS THROMBOSIS 2 0.0024
135 TYMPANIC MEMBRANE PERFORATION 4 0.0024
136 ATYPICAL PNEUMONIA 7 0.0023
137 ENTEROVIRUS INFECTION 2 0.0023
138 VIRAL INFECTION 77 0.0023
139 GASTROENTERITIS VIRAL 41 0.0023
140 OBSTRUCTION 9 0.0023
141 EYE INFECTION 25 0.0022
142 COVID-19 PNEUMONIA 26 0.0022
143 PHARYNGITIS STREPTOCOCCAL 23 0.0021
144 OTITIS MEDIA 7 0.0021
145 CONNECTIVE TISSUE DISORDER 3 0.0021
146 BLOOD ELECTROLYTES DECREASED 3 0.0021
147 INJECTION SITE SCAR 6 0.0021
148 MENINGITIS 14 0.0021
149 BRONCHITIS 155 0.0021
150 BRONCHIECTASIS 14 0.0021
151 HEREDITARY ANGIOEDEMA 22 0.0020
152 TOOTH INFECTION 27 0.0020
153 PRECANCEROUS SKIN LESION 3 0.0020
154 CHOLANGIOCARCINOMA 3 0.0020
155 INFUSION RELATED REACTION 133 0.0020
156 EAR DISORDER 9 0.0020
157 RUBBER SENSITIVITY 3 0.0020
158 PNEUMONIA PSEUDOMONAL 3 0.0020
159 PRODUCT TEMPERATURE EXCURSION ISSUE 10 0.0019
160 CORONAVIRUS TEST POSITIVE 2 0.0019
161 EYE ALLERGY 3 0.0019
162 INTERVERTEBRAL DISC COMPRESSION 2 0.0019
163 CHRONIC LYMPHOCYTIC LEUKAEMIA 9 0.0019
164 GASTROINTESTINAL INFECTION 17 0.0019
165 PHARYNGEAL PARAESTHESIA 3 0.0019
166 FOOD POISONING 10 0.0019
167 HORDEOLUM 8 0.0018
168 SKIN LACERATION 20 0.0018
169 SUSPECTED COVID-19 6 0.0018
170 MIDDLE EAR EFFUSION 4 0.0018
171 ARTHROPOD STING 3 0.0018
172 SERUM SICKNESS 5 0.0018
173 SALMONELLOSIS 3 0.0018
174 LOWER RESPIRATORY TRACT CONGESTION 3 0.0018
175 VASCULAR DEVICE INFECTION 8 0.0018
176 PHARYNGEAL SWELLING 17 0.0017
177 LOCALISED INFECTION 42 0.0017
178 CHRONIC SPONTANEOUS URTICARIA 2 0.0017
179 ILLNESS 176 0.0017
180 BILE DUCT CANCER 2 0.0017
181 AUTOIMMUNE DISORDER 16 0.0016
182 LARGE INTESTINE INFECTION 2 0.0016
183 WEIGHT FLUCTUATION 17 0.0016
184 INTRA-ABDOMINAL HAEMATOMA 2 0.0016
185 PHARYNGITIS 20 0.0016
186 PRODUCT LEAKAGE 9 0.0016
187 BONE MARROW TRANSPLANT 3 0.0016
188 PRODUCT CONTAMINATION PHYSICAL 4 0.0016
189 BRONCHIAL SECRETION RETENTION 2 0.0016
190 ADRENAL DISORDER 3 0.0016
191 DRUG DELIVERY SYSTEM ISSUE 3 0.0015
192 UNDERWEIGHT 3 0.0015
193 VOCAL CORD DISORDER 3 0.0015
194 PLEURISY 9 0.0015
195 ABDOMINAL MASS 4 0.0015
196 RESPIRATORY SYNCYTIAL VIRUS INFECTION 13 0.0015
197 MYCOBACTERIUM AVIUM COMPLEX INFECTION 4 0.0015
198 INJECTION SITE DISCHARGE 8 0.0015
199 FUNGAL SKIN INFECTION 6 0.0015
200 EAR HAEMORRHAGE 3 0.0015
201 POST PROCEDURAL INFECTION 12 0.0015
202 NONSPECIFIC REACTION 8 0.0015
203 DISCHARGE 2 0.0014
204 H1N1 INFLUENZA 2 0.0014
205 EAR SWELLING 3 0.0014
206 OXYGEN SATURATION ABNORMAL 4 0.0014
207 RESPIRATORY SYMPTOM 4 0.0014
208 PSEUDOMONAS INFECTION 12 0.0014
209 HYPOTHALAMO-PITUITARY DISORDER 2 0.0014
210 HYPOGAMMAGLOBULINAEMIA 9 0.0014
211 EXCESSIVE EYE BLINKING 2 0.0014
212 INFLUENZA 150 0.0013
213 TENDERNESS 14 0.0013
214 INFECTION 194 0.0013
215 NEEDLE ISSUE 39 0.0013
216 PARANASAL SINUS DISCOMFORT 5 0.0013
217 PERIARTHRITIS 3 0.0013
218 PNEUMONIA BACTERIAL 12 0.0013
219 INJECTION SITE PARAESTHESIA 2 0.0013
220 IMMUNE-MEDIATED ADVERSE REACTION 2 0.0013
221 INJECTION SITE EXTRAVASATION 16 0.0013
222 ARTHRITIS INFECTIVE 6 0.0013
223 CONCUSSION 10 0.0013
224 INFUSION SITE INFECTION 3 0.0013
225 ORAL INFECTION 5 0.0013
226 TOOTH ABSCESS 13 0.0013
227 SKIN TIGHTNESS 6 0.0013
228 PRODUCT SUPPLY ISSUE 9 0.0013
229 PNEUMONIA VIRAL 4 0.0013
230 COVID-19 220 0.0013
231 RHINITIS 10 0.0012
232 BRONCHITIS CHRONIC 3 0.0012
233 HAEMATOLOGICAL INFECTION 3 0.0012
234 MIGRAINE 117 0.0012
235 CYSTITIS 39 0.0012
236 EYE OEDEMA 3 0.0012
237 SENSITIVE SKIN 9 0.0012
238 ESCHERICHIA INFECTION 10 0.0012
239 INJECTION RELATED REACTION 2 0.0012
240 NEAR DEATH EXPERIENCE 4 0.0012
241 CORONAVIRUS INFECTION 8 0.0012
242 GASTRIC DILATATION 2 0.0012
243 VEIN DISORDER 6 0.0012
244 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 216 0.0012
245 CANDIDA INFECTION 20 0.0012
246 LIMB INJURY 32 0.0012
247 EXPOSURE TO SARS-COV-2 2 0.0012
248 FOOD ALLERGY 9 0.0012
249 CERVICAL SPINAL STENOSIS 2 0.0012
250 ACUTE SINUSITIS 2 0.0012
251 AMYLOIDOSIS 2 0.0012
252 CATHETER SITE PAIN 3 0.0012
253 URINARY TRACT INFECTION 195 0.0011
254 FUNGAL INFECTION 38 0.0011
255 ANIMAL BITE 3 0.0011
256 CYTOMEGALOVIRUS VIRAEMIA 5 0.0011
257 MYASTHENIA GRAVIS 9 0.0011
258 GINGIVITIS 6 0.0011
259 ABDOMINAL RIGIDITY 3 0.0011
260 ASTHMA 123 0.0011
261 BRAIN FOG 17 0.0011
262 ARTHROPOD BITE 8 0.0011
263 HEART RATE ABNORMAL 6 0.0011
264 BACTERIAL INFECTION 20 0.0011
265 BLADDER SPASM 2 0.0011
266 BLOOD PRESSURE ABNORMAL 21 0.0011
267 LOWER RESPIRATORY TRACT INFECTION 48 0.0011
268 GASTRIC INFECTION 4 0.0010
269 SKIN SWELLING 9 0.0010
270 PNEUMONIA FUNGAL 4 0.0010
271 WOUND INFECTION 11 0.0010
272 MASS 14 0.0010
273 NASOPHARYNGITIS 184 0.0010
274 CENTRAL VENOUS CATHETERISATION 3 0.0010
275 CARDIAC DISCOMFORT 2 0.0010
276 SCAR 17 0.0010
277 FRUSTRATION TOLERANCE DECREASED 8 0.0010
278 SARS-COV-2 TEST POSITIVE 13 0.0010
279 SWELLING 91 0.0010
280 ANAPHYLACTOID REACTION 4 0.0010
281 STAPHYLOCOCCAL INFECTION 32 0.0010
282 INCORRECT PRODUCT ADMINISTRATION DURATION 21 0.0010
283 INJECTION SITE DISCOMFORT 10 0.0009
284 RENAL PAIN 10 0.0009
285 MUSCLE STRAIN 8 0.0009
286 INCORRECT DISPOSAL OF PRODUCT 3 0.0009
287 INFLUENZA LIKE ILLNESS 76 0.0009
288 POLYP 6 0.0009
289 GASTROINTESTINAL ULCER 2 0.0009
290 INJECTION SITE SWELLING 68 0.0009
291 OROPHARYNGEAL DISCOMFORT 8 0.0009
292 WOUND COMPLICATION 3 0.0009
293 PNEUMONIA 282 0.0009
294 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
295 SKIN ABRASION 4 0.0008
296 HERPES ZOSTER 48 0.0008
297 PRODUCT AVAILABILITY ISSUE 19 0.0008
298 CELLULITIS 42 0.0008
299 RIB FRACTURE 17 0.0008
300 BLOOD IMMUNOGLOBULIN E INCREASED 2 0.0008
301 SCLERODERMA 3 0.0008
302 FOOD INTOLERANCE 3 0.0008
303 DECREASED IMMUNE RESPONSIVENESS 8 0.0008
304 MUSCULOSKELETAL DISCOMFORT 14 0.0008
305 NASAL POLYPS 4 0.0008
306 HYPERACUSIS 3 0.0008
307 GASTROINTESTINAL DISORDER 72 0.0008
308 PRODUCT DOSE OMISSION ISSUE 233 0.0008
309 BLOOD PRESSURE DIASTOLIC ABNORMAL 2 0.0008
310 OESOPHAGEAL DISORDER 3 0.0008
311 HERNIA 15 0.0008
312 ANKLE FRACTURE 12 0.0008
313 HERPES SIMPLEX 5 0.0008
314 TENDON DISORDER 5 0.0008
315 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
316 EXFOLIATIVE RASH 2 0.0008
317 CHILLS 89 0.0008
318 CONTUSION 73 0.0008
319 HEADACHE 475 0.0008
320 CEREBRAL ATROPHY 3 0.0008
321 SKIN MASS 5 0.0007
322 LEUKAEMIA 7 0.0007
323 NEURALGIA 18 0.0007
324 SINUS CONGESTION 10 0.0007
325 SPINAL FUSION SURGERY 3 0.0007
326 HIP SURGERY 4 0.0007
327 LUNG DISORDER 36 0.0007
328 LYMPHADENOPATHY 26 0.0007
329 TRIGGER FINGER 3 0.0007
330 PULMONARY THROMBOSIS 8 0.0007
331 CLOSTRIDIUM DIFFICILE INFECTION 16 0.0007
332 AUTISM SPECTRUM DISORDER 4 0.0007
333 EOSINOPHILIC OESOPHAGITIS 2 0.0007
334 ANGIOPATHY 4 0.0007
335 THYROID DISORDER 11 0.0007
336 LYMPHOMA 11 0.0007
337 ABDOMINAL DISTENSION 74 0.0007
338 MUSCLE FATIGUE 3 0.0007
339 LIGAMENT SPRAIN 7 0.0007
340 FORCED EXPIRATORY VOLUME DECREASED 2 0.0007
341 ANAPHYLACTIC REACTION 39 0.0007
342 ABSCESS LIMB 3 0.0007
343 MOUTH SWELLING 4 0.0007
344 RESPIRATORY TRACT CONGESTION 11 0.0007
345 SKIN WARM 4 0.0007
346 PULMONARY FUNCTION TEST DECREASED 3 0.0007
347 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
348 ORAL CANDIDIASIS 9 0.0007
349 GROIN PAIN 6 0.0007
350 PARONYCHIA 3 0.0007
351 EAR DISCOMFORT 7 0.0007
352 TRANSIENT ISCHAEMIC ATTACK 23 0.0007
353 BACK DISORDER 11 0.0007
354 CREPITATIONS 2 0.0007
355 GOUT 12 0.0007
356 POOR QUALITY PRODUCT ADMINISTERED 7 0.0007
357 TYPE 1 DIABETES MELLITUS 4 0.0007
358 SKIN CANCER 14 0.0006
359 FIBROSIS 2 0.0006
360 SYNOVIAL CYST 3 0.0006
361 PREGNANCY 13 0.0006
362 THROMBOSIS 52 0.0006
363 APHONIA 9 0.0006
364 BACK INJURY 7 0.0006
365 BLOOD BLISTER 2 0.0006
366 BLOOD CREATININE DECREASED 2 0.0006
367 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
368 BODY TEMPERATURE INCREASED 13 0.0006
369 RESPIRATORY DISORDER 19 0.0006
370 ABDOMINAL ADHESIONS 2 0.0006
371 FOOT FRACTURE 12 0.0006
372 NEPHROLITHIASIS 29 0.0006
373 NO ADVERSE EVENT 114 0.0006
374 ENDOMETRIOSIS 3 0.0006
375 SYRINGE ISSUE 11 0.0006
376 SCIATICA 10 0.0006
377 URTICARIA 105 0.0006
378 LIMB OPERATION 3 0.0006
379 PARAESTHESIA ORAL 9 0.0006
380 INJECTION SITE MASS 23 0.0006
381 HAEMOGLOBIN ABNORMAL 4 0.0006
382 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
383 SCAB 7 0.0006
384 PANCREATIC DISORDER 3 0.0006
385 BREATH SOUNDS ABNORMAL 3 0.0006
386 DIABETIC NEUROPATHY 3 0.0006
387 INJECTION SITE ERYTHEMA 75 0.0006
388 ABDOMINAL TENDERNESS 3 0.0006
389 POOR QUALITY SLEEP 13 0.0006
390 ADVERSE REACTION 8 0.0006
391 VASCULITIS 7 0.0006
392 HEAD INJURY 19 0.0006
393 INTERVERTEBRAL DISC PROTRUSION 13 0.0006
394 HYPERSOMNIA 17 0.0006
395 POSTOPERATIVE WOUND INFECTION 4 0.0006
396 BLOOD IRON DECREASED 7 0.0006
397 HEPATIC CYST 2 0.0006
398 THERAPY INTERRUPTED 42 0.0006
399 IMPAIRED GASTRIC EMPTYING 8 0.0006
400 PHLEBITIS 3 0.0006
401 PRODUCT COLOUR ISSUE 3 0.0006
402 HELICOBACTER INFECTION 6 0.0006
403 PYREXIA 201 0.0006
404 NASAL CONGESTION 34 0.0006
405 ACUTE MYELOID LEUKAEMIA 9 0.0006
406 ADRENAL INSUFFICIENCY 7 0.0006
407 HYPOPNOEA 2 0.0006
408 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 30 0.0006
409 PULMONARY FIBROSIS 11 0.0006
410 NECK PAIN 32 0.0006
411 URINE OUTPUT DECREASED 5 0.0006
412 PRODUCT USE COMPLAINT 9 0.0006
413 PRODUCT STORAGE ERROR 50 0.0006
414 RIGHT VENTRICULAR FAILURE 4 0.0006
415 SERUM FERRITIN INCREASED 3 0.0006
416 SKIN REACTION 8 0.0006
417 FULL BLOOD COUNT ABNORMAL 6 0.0006
418 PRODUCTIVE COUGH 27 0.0006
419 GLOSSITIS 2 0.0006
420 FEAR OF INJECTION 4 0.0006
421 COMPRESSION FRACTURE 3 0.0006
422 HAEMOLYTIC ANAEMIA 5 0.0006
423 HAEMARTHROSIS 5 0.0006
424 STRESS FRACTURE 3 0.0006
425 BEHAVIOUR DISORDER 3 0.0006
426 OSTEOMYELITIS 10 0.0006
427 INJECTION SITE IRRITATION 7 0.0005
428 LIMB DISCOMFORT 17 0.0005
429 SPINAL FRACTURE 11 0.0005
430 FAECALOMA 3 0.0005
431 DEAFNESS UNILATERAL 3 0.0005
432 PRODUCT ADMINISTRATION ERROR 11 0.0005
433 BLOOD PRESSURE INCREASED 83 0.0005
434 PSYCHIATRIC SYMPTOM 4 0.0005
435 OROPHARYNGEAL PAIN 50 0.0005
436 INJECTION SITE INDURATION 7 0.0005
437 NEOPLASM MALIGNANT 36 0.0005
438 CONJUNCTIVITIS 10 0.0005
439 NECROSIS 3 0.0005
440 INTENTIONAL PRODUCT USE ISSUE 47 0.0005
441 NODULE 7 0.0005
442 OCULAR DISCOMFORT 6 0.0005
443 IMMUNE SYSTEM DISORDER 7 0.0005
444 MALAISE 232 0.0005
445 CHEST DISCOMFORT 54 0.0005
446 SPUTUM DISCOLOURED 5 0.0005
447 INTERNAL HAEMORRHAGE 6 0.0005
448 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
449 THROAT TIGHTNESS 14 0.0005
450 FATIGUE 402 0.0005
451 EAR PAIN 10 0.0005
452 FAECES HARD 2 0.0005
453 IRRITABLE BOWEL SYNDROME 11 0.0005
454 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
455 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
456 PRURITUS GENERALISED 11 0.0005
457 THERAPY CHANGE 5 0.0005
458 DIVERTICULITIS 14 0.0005
459 BLADDER DISORDER 5 0.0005
460 STENT PLACEMENT 4 0.0005
461 INJECTION SITE VESICLES 3 0.0005
462 EMPHYSEMA 5 0.0005
463 CARDIOMEGALY 6 0.0005
464 SPINAL OPERATION 6 0.0005
465 INJECTION SITE WARMTH 10 0.0005
466 SCOLIOSIS 3 0.0005
467 ARTHRITIS 38 0.0005
468 PERIPHERAL SWELLING 74 0.0005
469 SWOLLEN TONGUE 15 0.0005
470 EOSINOPHIL COUNT INCREASED 4 0.0005
471 PETECHIAE 5 0.0005
472 SYSTEMIC LUPUS ERYTHEMATOSUS 17 0.0005
473 FOLLICULITIS 5 0.0005
474 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
475 JOINT DISLOCATION 5 0.0005
476 SCREAMING 3 0.0005
477 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
478 FACIAL PARALYSIS 4 0.0005
479 INTERVERTEBRAL DISC DISORDER 2 0.0005
480 PRODUCT CONTAINER ISSUE 4 0.0005
481 HAEMATOMA 12 0.0005
482 COUGH 129 0.0005
483 ASPIRATION 5 0.0005
484 BURNING SENSATION 32 0.0005
485 INJECTION SITE RASH 14 0.0005
486 GASTRITIS 12 0.0005
487 COLD SWEAT 8 0.0005
488 FIBROMYALGIA 11 0.0005
489 RESPIRATORY RATE INCREASED 4 0.0005
490 SKIN DISORDER 15 0.0004
491 TOOTH DISORDER 10 0.0004
492 NERVE INJURY 5 0.0004
493 WRONG PRODUCT ADMINISTERED 3 0.0004
494 DISEASE COMPLICATION 2 0.0004
495 IMMUNE THROMBOCYTOPENIA 2 0.0004
496 JOINT EFFUSION 3 0.0004
497 NEOPLASM 5 0.0004
498 ENCEPHALITIS 3 0.0004
499 UROSEPSIS 4 0.0004
500 NERVE COMPRESSION 4 0.0004
501 FLUID RETENTION 22 0.0004
502 WEIGHT INCREASED 96 0.0004
503 APPENDICITIS 4 0.0004
504 BLISTER 24 0.0004
505 SPINAL PAIN 5 0.0004
506 ADVERSE DRUG REACTION 38 0.0004
507 SPINAL DISORDER 4 0.0004
508 ECZEMA 22 0.0004
509 GAIT INABILITY 14 0.0004
510 INJECTION SITE PRURITUS 28 0.0004
511 IMPAIRED QUALITY OF LIFE 6 0.0004
512 LOWER LIMB FRACTURE 8 0.0004
513 SEPSIS 46 0.0004
514 WEIGHT DECREASED 115 0.0004
515 GASTROENTERITIS 6 0.0004
516 UTERINE LEIOMYOMA 3 0.0004
517 OXYGEN SATURATION DECREASED 23 0.0004
518 FEELING ABNORMAL 98 0.0004
519 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
520 CEREBRAL DISORDER 3 0.0004
521 HYPERVOLAEMIA 2 0.0004
522 IMMUNODEFICIENCY 6 0.0004
523 SUNBURN 3 0.0004
524 INJECTION SITE INFLAMMATION 2 0.0004
525 HEPATIC ENZYME ABNORMAL 2 0.0004
526 RASH MACULAR 14 0.0004
527 INJECTION SITE DISCOLOURATION 5 0.0004
528 FLUID INTAKE REDUCED 2 0.0004
529 SECRETION DISCHARGE 5 0.0004
530 CORONARY ARTERIAL STENT INSERTION 2 0.0004
531 GALLBLADDER DISORDER 7 0.0004
532 PROCEDURAL COMPLICATION 3 0.0004
533 FEMORAL NECK FRACTURE 2 0.0004
534 DEVICE RELATED INFECTION 6 0.0004
535 INCREASED UPPER AIRWAY SECRETION 2 0.0004
536 MUSCULOSKELETAL CHEST PAIN 6 0.0004
537 HIATUS HERNIA 5 0.0004
538 EYE DISCHARGE 4 0.0004
539 ERYTHEMA 79 0.0004
540 PRODUCT USE ISSUE 72 0.0004
541 FALL 127 0.0004
542 PRURITUS 145 0.0004
543 DISCOMFORT 23 0.0004
544 DYSPHONIA 22 0.0004
545 ATRIAL FLUTTER 3 0.0004
546 JOINT INJURY 8 0.0004
547 BLOOD DISORDER 3 0.0004
548 MOVEMENT DISORDER 12 0.0004
549 PHOTOPHOBIA 7 0.0004
550 HYPERSENSITIVITY 69 0.0004
551 MUSCLE DISORDER 3 0.0004
552 HEART RATE DECREASED 13 0.0004
553 DECUBITUS ULCER 3 0.0004
554 HYDROCEPHALUS 2 0.0004
555 INJECTION SITE URTICARIA 9 0.0004
556 JAW DISORDER 2 0.0004
557 POST PROCEDURAL COMPLICATION 7 0.0004
558 PAIN 223 0.0004
559 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
560 DENTAL CARIES 4 0.0004
561 CYSTIC FIBROSIS 2 0.0004
562 LIP SWELLING 12 0.0004
563 ROAD TRAFFIC ACCIDENT 15 0.0004
564 WOUND 10 0.0004
565 MALNUTRITION 4 0.0004
566 STATUS EPILEPTICUS 4 0.0004
567 WHEEZING 21 0.0004
568 CARDIAC DISORDER 33 0.0004
569 HOSPITALISATION 54 0.0004
570 UPPER LIMB FRACTURE 7 0.0004
571 INJECTION SITE BRUISING 28 0.0004
572 BRONCHOSPASM 5 0.0004
573 INJECTION SITE REACTION 24 0.0003
574 MUSCLE TWITCHING 8 0.0003
575 ENTEROCOLITIS 2 0.0003
576 FEEDING DISORDER 7 0.0003
577 INTESTINAL OBSTRUCTION 13 0.0003
578 ELECTROLYTE IMBALANCE 4 0.0003
579 NAIL DISORDER 3 0.0003
580 MUSCULOSKELETAL STIFFNESS 30 0.0003
581 HIP FRACTURE 11 0.0003
582 RHINORRHOEA 22 0.0003
583 BACK PAIN 79 0.0003
584 NAUSEA 269 0.0003
585 HEAD DISCOMFORT 6 0.0003
586 ENERGY INCREASED 2 0.0003
587 RASH 147 0.0003
588 PULMONARY HYPERTENSION 7 0.0003
589 PULMONARY MASS 5 0.0003
590 ACCIDENT 4 0.0003
591 EYE DISORDER 11 0.0003
592 WRIST FRACTURE 4 0.0003
593 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
594 BLOOD PRESSURE DECREASED 22 0.0003
595 BURSITIS 4 0.0003
596 ILL-DEFINED DISORDER 20 0.0003
597 INCORRECT DOSE ADMINISTERED 75 0.0003
598 BRAIN NEOPLASM 3 0.0003
599 INCREASED TENDENCY TO BRUISE 3 0.0003
600 LIVER FUNCTION TEST INCREASED 7 0.0003
601 PROCEDURAL PAIN 9 0.0003
602 TENDON RUPTURE 4 0.0003
603 CHEST PAIN 60 0.0003
604 DEVICE LEAKAGE 14 0.0003
605 CYST 4 0.0003
606 RENAL DISORDER 15 0.0003
607 BASAL CELL CARCINOMA 5 0.0003
608 FLANK PAIN 3 0.0003
609 PAIN IN EXTREMITY 94 0.0003
610 BLOOD URINE PRESENT 6 0.0003
611 MUSCLE ATROPHY 4 0.0003
612 PRODUCT USE IN UNAPPROVED INDICATION 78 0.0003
613 SLEEP APNOEA SYNDROME 6 0.0003
614 ULCER 5 0.0003
615 ENTERITIS 2 0.0003
616 RASH PAPULAR 7 0.0003
617 SNEEZING 7 0.0003
618 ROTATOR CUFF SYNDROME 4 0.0003
619 ANAPHYLACTIC SHOCK 8 0.0003
620 INFLAMMATION 16 0.0003
621 CARDIAC FLUTTER 2 0.0003
622 ORAL HERPES 6 0.0003
623 SWELLING FACE 20 0.0003
624 PLATELET COUNT INCREASED 4 0.0003
625 COELIAC DISEASE 3 0.0003
626 HEPATOMEGALY 3 0.0003
627 SKIN DISCOLOURATION 14 0.0003
628 CYTOMEGALOVIRUS INFECTION 5 0.0003
629 OVARIAN CYST 3 0.0003
630 INJECTION SITE PAIN 92 0.0003
631 BLOOD POTASSIUM DECREASED 9 0.0003
632 DIZZINESS 149 0.0003
633 DYSPNOEA 169 0.0003
634 BREAST MASS 2 0.0003
635 PERICARDITIS 5 0.0003
636 PRODUCT PHYSICAL ISSUE 6 0.0003
637 COLITIS ISCHAEMIC 2 0.0003
638 HYPERHIDROSIS 38 0.0003
639 MOTOR DYSFUNCTION 3 0.0003
640 SEIZURE 34 0.0003
641 PALPITATIONS 34 0.0003
642 MENTAL IMPAIRMENT 7 0.0003
643 LARGE INTESTINE POLYP 2 0.0003
644 FEELING COLD 8 0.0003
645 ORTHOSTATIC HYPOTENSION 5 0.0003
646 DEVICE USE ISSUE 5 0.0003
647 CARPAL TUNNEL SYNDROME 4 0.0003
648 INCONTINENCE 3 0.0003
649 HEART RATE INCREASED 28 0.0003
650 HAND FRACTURE 2 0.0003
651 DRUG ERUPTION 5 0.0003
652 INTENTIONAL DOSE OMISSION 8 0.0003
653 BODY HEIGHT DECREASED 3 0.0003
654 DRUG INTOLERANCE 27 0.0003
655 PARALYSIS 4 0.0003
656 VERTIGO 17 0.0003
657 GRAFT VERSUS HOST DISEASE 2 0.0003
658 BALANCE DISORDER 24 0.0003
659 DEHYDRATION 37 0.0003
660 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
661 EXPOSURE DURING PREGNANCY 17 0.0003
662 SURGERY 16 0.0003
663 GASTROINTESTINAL PAIN 3 0.0003
664 INJECTION SITE NODULE 3 0.0003
665 SKIN ULCER 7 0.0003
666 VOMITING 127 0.0003
667 CATARACT 16 0.0003
668 EYE PRURITUS 9 0.0003
669 HYPOAESTHESIA 40 0.0003
670 HYDRONEPHROSIS 2 0.0003
671 HEPATIC CIRRHOSIS 5 0.0003
672 CHROMATURIA 6 0.0003
673 CEREBROVASCULAR ACCIDENT 45 0.0003
674 REBOUND EFFECT 3 0.0003
675 BLOOD SODIUM DECREASED 5 0.0003
676 APHASIA 8 0.0003
677 MYALGIA 45 0.0003
678 ARTHRALGIA 110 0.0003
679 GASTRIC ULCER 5 0.0003
680 INJECTION SITE HAEMORRHAGE 21 0.0003
681 BOWEL MOVEMENT IRREGULARITY 2 0.0003
682 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
683 DISTURBANCE IN ATTENTION 14 0.0003
684 TACHYCARDIA 23 0.0003
685 ATRIAL FIBRILLATION 25 0.0003
686 ABDOMINAL DISCOMFORT 43 0.0003
687 GASTROINTESTINAL INFLAMMATION 2 0.0003
688 MEMORY IMPAIRMENT 35 0.0003
689 ATAXIA 3 0.0003
690 PNEUMOTHORAX 4 0.0003
691 ABSCESS 4 0.0003
692 MUSCLE SPASMS 46 0.0003
693 BLOOD PRESSURE FLUCTUATION 6 0.0002
694 GASTROOESOPHAGEAL REFLUX DISEASE 20 0.0002
695 ASTHENIA 93 0.0002
696 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7 0.0002
697 MUSCLE TIGHTNESS 4 0.0002
698 DEPRESSED MOOD 13 0.0002
699 PRODUCT DOSE OMISSION 16 0.0002
700 DYSURIA 9 0.0002
701 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
702 SMALL INTESTINAL OBSTRUCTION 3 0.0002
703 CONDITION AGGRAVATED 74 0.0002
704 HAIR DISORDER 2 0.0002
705 PULMONARY EMBOLISM 23 0.0002
706 TOOTH EXTRACTION 3 0.0002
707 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
708 TREMOR 40 0.0002
709 SLEEP DISORDER 17 0.0002
710 EPISTAXIS 18 0.0002
711 HAEMORRHAGE 25 0.0002
712 DERMATITIS 5 0.0002
713 KNEE ARTHROPLASTY 5 0.0002
714 COLITIS 9 0.0002
715 FLUSHING 24 0.0002
716 PRODUCT QUALITY ISSUE 32 0.0002
717 EATING DISORDER 5 0.0002
718 RETCHING 5 0.0002
719 ARTHROPATHY 13 0.0002
720 ABDOMINAL PAIN UPPER 48 0.0002
721 IRRITABILITY 14 0.0002
722 RASH GENERALISED 6 0.0002
723 CARDIAC MURMUR 2 0.0002
724 HYSTERECTOMY 2 0.0002
725 PLASMA CELL MYELOMA 9 0.0002
726 RASH ERYTHEMATOUS 11 0.0002
727 MENTAL DISORDER 10 0.0002
728 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
729 PULMONARY CONGESTION 3 0.0002
730 HYPERTENSION 48 0.0002
731 UNEVALUABLE EVENT 17 0.0002
732 DIARRHOEA 145 0.0002
733 MALIGNANT MELANOMA 3 0.0002
734 ABDOMINAL PAIN 52 0.0002
735 PAIN OF SKIN 6 0.0002
736 ANAL INCONTINENCE 2 0.0002
737 RASH PRURITIC 12 0.0002
738 PALLOR 6 0.0002
739 CRYING 8 0.0002
740 PERIPHERAL COLDNESS 3 0.0002
741 IRON DEFICIENCY ANAEMIA 2 0.0002
742 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
743 JOINT SWELLING 26 0.0002
744 DEMENTIA 6 0.0002
745 IMPAIRED HEALING 7 0.0002
746 DEVICE OCCLUSION 3 0.0002
747 ARTERIOSCLEROSIS 2 0.0002
748 OSTEOARTHRITIS 9 0.0002
749 FEELING HOT 13 0.0002
750 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
751 NERVOUSNESS 11 0.0002
752 LETHARGY 12 0.0002
753 ANOSMIA 3 0.0002
754 FLUID OVERLOAD 3 0.0002
755 BONE PAIN 12 0.0002
756 INFLAMMATORY BOWEL DISEASE 2 0.0002
757 PARAESTHESIA 32 0.0002
758 KNEE OPERATION 2 0.0002
759 BODY TEMPERATURE DECREASED 2 0.0002
760 URINARY INCONTINENCE 6 0.0002
761 HOSPICE CARE 2 0.0002
762 THROAT IRRITATION 9 0.0002
763 PNEUMONIA ASPIRATION 5 0.0002
764 SYNCOPE 20 0.0002
765 CYTOKINE RELEASE SYNDROME 4 0.0002
766 HYPOAESTHESIA ORAL 3 0.0002
767 HYPOXIA 7 0.0002
768 ABDOMINAL PAIN LOWER 5 0.0002
769 INJURY ASSOCIATED WITH DEVICE 4 0.0002
770 TINNITUS 9 0.0002
771 LOSS OF CONSCIOUSNESS 25 0.0002
772 PHARYNGEAL OEDEMA 3 0.0002
773 INITIAL INSOMNIA 2 0.0002
774 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
775 OSTEOPOROSIS 8 0.0002
776 SOMNOLENCE 39 0.0002
777 MUSCULAR WEAKNESS 22 0.0002
778 NERVOUS SYSTEM DISORDER 6 0.0002
779 JOINT STIFFNESS 5 0.0002
780 RENAL IMPAIRMENT 16 0.0002
781 DEVICE ISSUE 17 0.0002
782 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
783 DYSPNOEA EXERTIONAL 7 0.0002
784 RHEUMATOID ARTHRITIS 21 0.0002
785 BLOOD POTASSIUM INCREASED 3 0.0002
786 PRODUCT PRESCRIBING ISSUE 4 0.0002
787 MULTIPLE FRACTURES 3 0.0002
788 VENTRICULAR TACHYCARDIA 3 0.0002
789 PHOTOSENSITIVITY REACTION 3 0.0002
790 RESPIRATORY DISTRESS 5 0.0002
791 COAGULOPATHY 3 0.0002
792 INTESTINAL PERFORATION 2 0.0002
793 UNDERDOSE 13 0.0002
794 FISTULA 2 0.0002
795 EYE PAIN 10 0.0002
796 HEART RATE IRREGULAR 4 0.0002
797 CHOLECYSTECTOMY 2 0.0002
798 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
799 GASTRIC HAEMORRHAGE 2 0.0002
800 HOT FLUSH 13 0.0002
801 DEVICE BREAKAGE 7 0.0002
802 GAIT DISTURBANCE 33 0.0002
803 ANXIETY 49 0.0002
804 DIABETES MELLITUS 13 0.0002
805 LYMPHOCYTE COUNT DECREASED 3 0.0002
806 VISUAL IMPAIRMENT 21 0.0002
807 DEEP VEIN THROMBOSIS 11 0.0002
808 BACTERAEMIA 2 0.0002
809 PRODUCT PRESCRIBING ERROR 4 0.0002
810 STOMATITIS 10 0.0002
811 PRESYNCOPE 4 0.0002
812 PLEURAL EFFUSION 10 0.0002
813 CYTOPENIA 2 0.0002
814 BLOOD GLUCOSE ABNORMAL 3 0.0002
815 HYPERCALCAEMIA 2 0.0002
816 GENERALISED OEDEMA 2 0.0002
817 THINKING ABNORMAL 3 0.0002
818 MYOCARDIAL INFARCTION 28 0.0002
819 DYSARTHRIA 6 0.0002
820 FLATULENCE 9 0.0002
821 FRACTURE 3 0.0002
822 BRAIN OEDEMA 2 0.0002
823 LIVER DISORDER 7 0.0002
824 NEUROPATHY PERIPHERAL 15 0.0002
825 DEATH 135 0.0002
826 HYPOPHAGIA 4 0.0002
827 ACUTE RESPIRATORY FAILURE 3 0.0002
828 NIGHT SWEATS 5 0.0002
829 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
830 CHOKING 3 0.0002
831 MOBILITY DECREASED 11 0.0002
832 VISION BLURRED 21 0.0002
833 SKIN IRRITATION 7 0.0002
834 BEDRIDDEN 2 0.0002
835 DISABILITY 3 0.0002
836 DISORIENTATION 6 0.0002
837 BREAST CANCER 14 0.0002
838 COGNITIVE DISORDER 7 0.0001
839 EYE HAEMORRHAGE 2 0.0001
840 ABORTION SPONTANEOUS 6 0.0001
841 JOINT RANGE OF MOTION DECREASED 2 0.0001
842 FULL BLOOD COUNT DECREASED 3 0.0001
843 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
844 GINGIVAL BLEEDING 2 0.0001
845 PRODUCT PREPARATION ERROR 3 0.0001
846 LUNG NEOPLASM MALIGNANT 6 0.0001
847 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
848 MEDICATION ERROR 8 0.0001
849 BLOOD TEST ABNORMAL 2 0.0001
850 DYSPEPSIA 14 0.0001
851 RED BLOOD CELL COUNT DECREASED 4 0.0001
852 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 28 0.0001
853 PRODUCT DISPENSING ERROR 3 0.0001
854 RESPIRATORY FAILURE 10 0.0001
855 DYSSTASIA 4 0.0001
856 RESTLESSNESS 5 0.0001
857 RENAL FAILURE 18 0.0001
858 LABORATORY TEST ABNORMAL 4 0.0001
859 INSOMNIA 36 0.0001
860 BONE LOSS 2 0.0001
861 ALOPECIA 26 0.0001
862 SKIN EXFOLIATION 11 0.0001
863 CONFUSIONAL STATE 21 0.0001
864 PERICARDIAL EFFUSION 3 0.0001
865 GENERAL PHYSICAL HEALTH DETERIORATION 15 0.0001
866 DECREASED APPETITE 30 0.0001
867 TREATMENT NONCOMPLIANCE 7 0.0001
868 OFF LABEL USE 112 0.0001
869 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
870 OCULAR HYPERAEMIA 6 0.0001
871 DISEASE RECURRENCE 6 0.0001
872 HEPATIC CANCER 3 0.0001
873 EXTRA DOSE ADMINISTERED 5 0.0001
874 BLINDNESS 5 0.0001
875 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
876 AGGRESSION 6 0.0001
877 CIRCULATORY COLLAPSE 2 0.0001
878 GASTRIC DISORDER 4 0.0001
879 DYSPHAGIA 11 0.0001
880 DIPLOPIA 3 0.0001
881 ANAEMIA 22 0.0001
882 MUSCULOSKELETAL PAIN 6 0.0001
883 SPEECH DISORDER 6 0.0001
884 DEVICE MALFUNCTION 8 0.0001
885 INJURY 8 0.0001
886 PANCREATITIS 6 0.0001
887 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
888 ISCHAEMIC STROKE 2 0.0001
889 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
890 JAUNDICE 3 0.0001
891 THERAPY NON-RESPONDER 5 0.0001
892 OEDEMA 6 0.0001
893 C-REACTIVE PROTEIN INCREASED 4 0.0001
894 END STAGE RENAL DISEASE 2 0.0001
895 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
896 SKIN LESION 3 0.0001
897 AGITATION 8 0.0001
898 AMNESIA 7 0.0001
899 EYE SWELLING 4 0.0001
900 HEPATIC STEATOSIS 2 0.0001
901 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
902 HYPONATRAEMIA 6 0.0001
903 PAIN IN JAW 3 0.0001
904 ARRHYTHMIA 5 0.0001
905 FEELING JITTERY 2 0.0001
906 ANGINA PECTORIS 3 0.0001
907 INCREASED APPETITE 2 0.0001
908 EYE IRRITATION 6 0.0001
909 BLOOD GLUCOSE DECREASED 5 0.0001
910 INTERSTITIAL LUNG DISEASE 5 0.0001
911 HEPATIC ENZYME INCREASED 7 0.0001
912 HAEMORRHOIDS 2 0.0001
913 PSYCHOTIC DISORDER 3 0.0001
914 CONSTIPATION 22 0.0001
915 COMPLICATION OF DEVICE INSERTION 2 0.0001
916 CARDIAC FAILURE 8 0.0001
917 OEDEMA PERIPHERAL 12 0.0001
918 DYSKINESIA 4 0.0001
919 THERAPY CESSATION 5 0.0001
920 EMOTIONAL DISORDER 3 0.0001
921 FEMUR FRACTURE 3 0.0001
922 POLLAKIURIA 4 0.0001
923 DYSGEUSIA 7 0.0001
924 HYPOTHYROIDISM 3 0.0001
925 RECTAL HAEMORRHAGE 4 0.0001
926 HYPOACUSIS 4 0.0001
927 ACNE 7 0.0001
928 FAECES DISCOLOURED 2 0.0001
929 DEVICE DIFFICULT TO USE 6 0.0001
930 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
931 ANGIOEDEMA 4 0.0001
932 EXPIRED PRODUCT ADMINISTERED 3 0.0001
933 HYPOTENSION 18 0.0001
934 COLITIS ULCERATIVE 4 0.0001
935 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
936 NEUTROPENIA 12 0.0001
937 APPLICATION SITE PRURITUS 2 0.0001
938 SKIN BURNING SENSATION 6 0.0001
939 AGEUSIA 2 0.0001
940 DRY EYE 4 0.0001
941 DEPRESSION 18 0.0001
942 CHRONIC KIDNEY DISEASE 6 0.0001
943 HAEMOGLOBIN DECREASED 8 0.0001
944 BLOOD CREATININE INCREASED 5 0.0001
945 PSORIASIS 10 0.0001
946 DEAFNESS 2 0.0001
947 APPLICATION SITE ERYTHEMA 2 0.0001
948 PLATELET COUNT DECREASED 8 0.0001
949 CARDIAC FAILURE CONGESTIVE 6 0.0001
950 FREQUENT BOWEL MOVEMENTS 2 0.0001
951 DRY MOUTH 6 0.0001
952 PSORIATIC ARTHROPATHY 3 0.0001
953 NEUTROPHIL COUNT DECREASED 3 0.0001
954 HAEMATOCHEZIA 4 0.0001
955 HAEMOPTYSIS 2 0.0001
956 VAGINAL HAEMORRHAGE 3 0.0001
957 DEVICE DISLOCATION 3 0.0001
958 DRY SKIN 9 0.0001
959 LACRIMATION INCREASED 2 0.0001
960 CORONARY ARTERY DISEASE 2 0.0001
961 SUICIDAL IDEATION 6 0.0001
962 EPILEPSY 2 0.0001
963 BLOOD CHOLESTEROL INCREASED 3 0.0001
964 BONE DENSITY DECREASED 2 0.0001
965 DRUG INTERACTION 10 0.0001
966 COMA 3 0.0001
967 CHOLELITHIASIS 2 0.0001
968 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
969 ANGER 2 0.0001
970 DRUG INEFFECTIVE 77 0.0001
971 HAEMATURIA 2 0.0001
972 DELIRIUM 2 0.0001
973 HYPERKALAEMIA 2 0.0001
974 CEREBRAL HAEMORRHAGE 2 0.0001
975 ADVERSE EVENT 5 0.0001
976 BLOOD GLUCOSE INCREASED 10 0.0001
977 PRODUCT SUBSTITUTION ISSUE 3 0.0001
978 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
979 SUICIDE ATTEMPT 3 0.0000
980 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
981 THROMBOCYTOPENIA 5 0.0000
982 BRADYCARDIA 2 0.0000
983 FEBRILE NEUTROPENIA 2 0.0000
984 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
985 ACUTE KIDNEY INJURY 4 0.0000
986 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
987 CARDIAC ARREST 2 0.0000
988 OVERDOSE 5 0.0000
989 INTENTIONAL PRODUCT MISUSE 2 0.0000
990 EMOTIONAL DISTRESS 2 0.0000
991 DRUG DOSE OMISSION 2 0.0000